Vivorte, Inc

President and CEO

President & CEO of Vivorte, Inc.: https://vivorte.com/

Mark Wagner is the President & CEO of Vivorté, Inc., a commercial-stage orthobiologic company with two novel FDA-approved bone substitute cements, plus a pipeline of new technologies targeting emerging orthopedic treatments. Mr. Wagner has extensive experience leading commercial organizations within the orthopedics sector and broader medical device industry.  Prior to joining Vivorté, he held leadership positions with DCI Donor Services Tissue Bank, AmerisourceBergen Technology Group, Angiotech Pharmaceuticals and RTI Surgical. Mr. Wagner earned an MBA from the Kellogg School of Management at Northwestern University and received his undergraduate degree from Dartmouth College.